What You Should Know:
- Cala Health, the non-invasive bioelectronic medicine leader, today announced it has raised a $50 million growth round, co-led by Vertex Growth Fund and Nexus NeuroTech Ventures.
- All existing Cala investors participated in the round, including Action Potential, Johnson & Johnson, Lightstone, Lux, GV (Google Ventures), OSF Ventures, Ascension Ventures, TriVentures, Reimagined Ventures, Peak6 and Fiscus.
Cala Health: Revolutionizing Chronic Disease Care
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching
What You Should Know:
- Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
- The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.
Carta Healthcare and Realyze Intelligence:
Read More
Philips Partners with Baptist Health and NEFHSC to Bring Pregnancy+ Support to Florida Communities
What You Should Know:
The Northeast Florida Healthy Start Coalition (NEFHSC), in partnership with Baptist Health and Philips Avent, is expanding access to valuable pregnancy resources through a new initiative offering free subscriptions to the premium version of the Pregnancy+ app.
- This program aims to support expectant mothers and their families in Baker, Clay, and Duval counties, providing them with essential information and tools to promote healthy birth outcomes. This
Read More
Certis Oncology Launches AI-Powered Chatbot for Cancer Research
What You Should Know:
- Certis Oncology Solutions, a translational science and emerging technology leader in preclinical oncology research, is pleased to announce the commercial launch of CertisOI Assistant™, an innovative chatbot tool designed to enhance the efficiency and effectiveness of cancer research.
- This cutting-edge research tool leverages artificial intelligence/machine learning (AI/ML) and OpenAI’s ChatGPT language model to provide researchers unparalleled insights
Read More
Penn Medicine Partners with Cost Plus Drug Company to Enhance Medication Affordability
What You Should Know:
- Penn Medicine is teaming up with Mark Cuban's Cost Plus Drug Company to secure affordable generic medications for its patients.
- The strategic alliance will enable Penn Medicine to offer lower-cost prescriptions through its network of retail pharmacies, ultimately improving medication access and affordability for the community.
Addressing the Rising Cost of Medications
The cost of prescription drugs continues to be a significant barrier for many
Read More
The Role of Digitally Savvy Clinical Leadership Ready for the Future in Healthcare
As technological innovations, AI and challenges in healthcare continue to grow, it’s imperative for healthcare leaders – especially clinical ones – to be digitally competent and step into the forefront of change with skills and expertise to support a better future. Not only do they need to be efficient in use of existing technology to streamline operations and support frontline workers, but they also need to be open to new technologies in their workplaces to advance the industry, to pressure
Read More
Hinge Health, Amazon Partner to Expand Access to Musculoskeletal (MSK) Care
What You Should Know:
- Hinge Health announced a new collaboration with Amazon Health Services to feature Hinge Health’s leading musculoskeletal (MSK) care platform on Amazon.com. Hinge Health is the first digital MSK platform to join Amazon Health Services’ offering that aims to help people discover and enroll in digital health programs available through their employer or health plan at no additional cost.
- Approximately 40% of adults in the US suffer from a MSK condition, including
Read More
ConcertAI & NeoGenomics Launch CTO-H for Hematology Research
What You Should Know:
- ConcertAI and NeoGenomics (NASDAQ: NEO) announce a joint software-as-a-service solution in hematological malignancies for research analytics, clinical trial design, and clinical trial operational optimization.
- CTO-H provides a research data solution that is unprecedented in its scale, longitudinality and biomarker depth. CTO-H is a major outcome of the collaboration jointly announced on Jan. 8, 2024, and the more recent joint research completed and scheduled for
Read More
Offcall Launches with $2M for Financial & Career Platform for Physicians
What You Should Know:
- Offcall, a new digital platform designed specifically for physicians, has officially launched to address the growing financial and career challenges faced by doctors across the United States.
- Offcall has raised $2M in funding from investors, including Bloomberg Beta and Roar Ventures, as well as prominent physicians across the U.S. This investment will support the platform's growth and expansion of its offerings.
Addressing the Challenges Faced by
Read More
DeepHealth Chooses Ketryx to Accelerate AI-Powered Health Informatics Solutions
What You Should Know:
- Ketryx announced today that DeepHealth, Inc., a global leader in AI-powered health informatics and a wholly-owned subsidiary of RadNet, Inc. (Nasdaq: RDNT), has selected Ketryx to accelerate the delivery of AI-powered health informatics solutions.
-DeepHealth's solutions leverage a cloud-native operating system to drive operational efficiency, improved clinical confidence, and better care delivery. According to the FDA, radiology leads the way in AI/ML
Read More
